Factors such as the initial egg white-specific IgE level, grade of anaphylaxis at the challenge test, and respiratory symptoms during the challenge test showed significant differences between the subjects who obtained clinical tolerance and those who failed to do so. This evidence concerns the gene IGHE and anaphylaxis.